Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies.
about
Complete genome sequence of the N2-fixing broad host range endophyte Klebsiella pneumoniae 342 and virulence predictions verified in miceEffects of sulfamethizole and amdinocillin against Escherichia coli strains (with various susceptibilities) in an ascending urinary tract infection mouse modelIntracellular Bacterial Communities: A Potential Etiology for Chronic Lower Urinary Tract SymptomsInterplay in the selection of fluoroquinolone resistance and bacterial fitnessRole of enteroaggregative Escherichia coli virulence factors in uropathogenesis.Tetracycline rapidly reaches all the constituent cells of uropathogenic Escherichia coli biofilms.Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli.α-Intercalated cells defend the urinary system from bacterial infectionPersistence of uropathogenic Escherichia coli in the face of multiple antibioticsBiological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections.Noninvasive biophotonic imaging for monitoring of catheter-associated urinary tract infections and therapy in mice.Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defensesEstablishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection.Virulence of Escherichia coli B2 isolates from meat and animals in a murine model of ascending urinary tract infection (UTI): evidence that UTI is a zoonosis.Structure and function of Escherichia coli type 1 pili: new insight into the pathogenesis of urinary tract infections.A murine model of urinary tract infection.Characterization of a novel chaperone/usher fimbrial operon present on KpGI-5, a methionine tRNA gene-associated genomic island in Klebsiella pneumoniae.Detection of clonal group A Escherichia coli isolates from broiler chickens, broiler chicken meat, community-dwelling humans, and urinary tract infection (UTI) patients and their virulence in a mouse UTI model.Effect of ceftriaxone on the outcome of murine pyelonephritis caused by extended-spectrum-β-lactamase-producing Escherichia coli.Adhesion and entry of uropathogenic Escherichia coli.Pulsed-field gel electrophoresis typing of Escherichia coli strains from samples collected before and after pivmecillinam or placebo treatment of uncomplicated community-acquired urinary tract infection in womenForced resurgence and targeting of intracellular uropathogenic Escherichia coli reservoirsTransurethral induction of mouse urinary tract infection.Effects of a Mutation in the gyrA Gene on the Virulence of Uropathogenic Escherichia coli.Antibiotic treatment for urinary tract infections: pharmacokinetic/pharmacodynamic principles.Efficacy of ceftobiprole Medocaril against Enterococcus faecalis in a murine urinary tract infection modelEmerging drugs for bacterial urinary tract infections.Characterization of Klebsiella pneumoniae type 1 fimbriae by detection of phase variation during colonization and infection and impact on virulence.Uropathogenic Escherichia coli Metabolite-Dependent Quiescence and Persistence May Explain Antibiotic Tolerance during Urinary Tract InfectionUropathogenic Escherichia coli invades host cells via an HDAC6-modulated microtubule-dependent pathway.In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.Identification of a conserved chromosomal region encoding Klebsiella pneumoniae type 1 and type 3 fimbriae and assessment of the role of fimbriae in pathogenicityHigh rate of per oral mecillinam treatment failure in community-acquired urinary tract infections caused by ESBL-producing Escherichia coli.Invasion of Host Cells and Tissues by Uropathogenic Bacteria.Role of urinary cathelicidin LL-37 and human β-defensin 1 in uncomplicated Escherichia coli urinary tract infections.Cranberry Juice and Combinations of Its Organic Acids Are Effective against Experimental Urinary Tract Infection.Discovery and preclinical development of new antibiotics.Model systems for the study of Enterococcal colonization and infection.What is the role of covert infection in detrusor overactivity, and other LUTD? ICI-RS 2013.Type 1 pilus-mediated bacterial invasion of bladder epithelial cells.
P2860
Q21092477-E5931A01-8F28-41C8-A538-E89DBD3AF4CDQ24550534-C97244B6-6B98-43C5-AD4D-B9DA628112EAQ26799248-76191305-BCCC-4603-9A3B-B0817056F540Q28475870-E40733C4-4436-47DE-A766-1096A08F6E42Q30416927-98A7BC78-A350-4038-956F-13B41E87DAE7Q30837198-60A190DB-D6EF-470D-9855-D4F62ABCBF31Q33290835-C12FDE86-52E6-4F10-B690-074843BDD5D7Q33808284-25138CAA-B55C-43FF-89B2-DA55E4C1DC83Q33826366-2C199B96-8EC4-49F0-9FCC-ADF6618ED959Q33836664-3ACA5A21-6712-4E84-A4F1-23DA095AD4BFQ33883442-EA9CA8A2-6A78-4B9A-B452-D81169DDE335Q33988510-01421974-2A48-455D-A769-0B6682EA784EQ34008358-CF0108E9-D345-4269-8E4F-472CF4B46DF5Q34046483-F1A84BFF-39A5-4818-953D-1168A5863B34Q34136731-D03CECF6-2BC2-4FD0-BEBF-042BFE3FEBF9Q34236010-F6565F45-7BDF-4ACF-9FB2-1DEA0268C464Q34240855-29EEC01F-8666-4B9A-AF01-87E7E24FF625Q34432131-75649B26-8FBE-41EE-B4CC-353FF2529CC3Q34597721-09F4B826-15E5-4FBB-B1D8-D5C76CD63EBDQ34655354-AC84BEA9-CB60-4780-A124-100457841F17Q34680794-7D727BC2-33AC-4C93-A0D4-FFE62857081AQ35131385-3C7AB781-FBE2-4453-A429-83C391DBD0C6Q35164172-4BF0622E-D52D-475B-BE00-871DD9FA3AF5Q35860017-734E7DF2-D25C-479F-93E2-541A77B7736BQ35964763-FEBC2AD7-BAED-4173-B5F0-BED8FFB901D3Q36018587-E64FC792-A6C3-4EEC-B5F8-0DDDCB360444Q36150606-FDBF1A9D-0A9B-4105-9044-F52ECEC42DBAQ36845297-60AD0F83-4486-4FCA-B71D-90415EB6B584Q36891288-224A6D1E-D55C-402D-8DF0-8635A25528FCQ37029864-5BE47040-D055-4274-B61D-71FA125F2737Q37392858-AB4026B3-2D05-4FBE-BD84-D71E2635C3DDQ37410383-063F9A9F-63BD-4505-B603-B3A51A98B59EQ37484304-F4653B18-D09D-4CBF-837F-1F9B2CDC52AEQ37593454-7B26E854-176A-48C8-8E9D-244866AC639BQ37713225-8FC8F366-2C8A-42F2-9BBF-23EF6E04D5F4Q37735994-DA7DBBD5-2EAE-4ED2-B9B5-91E9BB35D2A0Q38197284-1ACAC0AF-4DD1-4D88-8B99-C77C0AEE1A3EQ38768532-958C2239-A730-489A-BC5C-F4221D5BD72FQ39189283-7827DF7A-738A-48E5-9C6C-CC0419BF69D0Q39922793-4DD9CE6D-A5BE-4B71-9DB6-5FDDFACA6C2E
P2860
Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Development of a long-term asc ...... antibiotic treatment studies.
@ast
Development of a long-term asc ...... antibiotic treatment studies.
@en
type
label
Development of a long-term asc ...... antibiotic treatment studies.
@ast
Development of a long-term asc ...... antibiotic treatment studies.
@en
prefLabel
Development of a long-term asc ...... antibiotic treatment studies.
@ast
Development of a long-term asc ...... antibiotic treatment studies.
@en
P2093
P2860
P1476
Development of a long-term asc ...... antibiotic treatment studies.
@en
P2093
H Hvidberg
K A Krogfelt
N Christensen
N Frimodt-Møller
S N Rasmussen
P2860
P304
P356
10.1128/AAC.44.1.156-163.2000
P407
P577
2000-01-01T00:00:00Z